The challenge of mild persistent asthma
Author: Irani, Anne-Marie
Source: Annals of Allergy, Asthma and Immunology, Volume 94, Number 5, May 2005 , pp. 517-527(11)
Publisher: American College of Allergy, Asthma, & Immunology
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
Objective: To review the current data and treatment options for mild persistent asthma. Data Sources: A MEDLINE search was performed for relevant articles. Study Selection: The expert opinion of the author was used to select studies for inclusion in this review. Results: Current data suggest that asthma severity is determined early in life and that disease progression may not occur outside early childhood. Furthermore, no therapy has been demonstrated to clearly prevent or reverse structural airway changes in patients with persistent asthma. Thus, the primary goal of asthma therapy is to prevent disease exacerbations rather than to halt disease progress, at least in patients past early childhood. Published reports of severe exacerbations in patients with reported mild asthma may actually reflect inclusion of patients with more severe forms of the disease who were inappropriately classified in terms of asthma severity. Conclusion: Unlike the case for moderate and severe asthma, where regular therapy with inhaled corticosteroids is clearly the treatment of choice, clear guidelines for treating patients with mild persistent asthma have not been established. Patients with mild disease without severe exacerbations may require only the minimum therapy necessary for disease control.Document Type: Review article
Key:
- Free Content
- New Content
- Subscribed Content
- Free Trial Content

Click here for Page Help